DARA BioSciences, Inc. (DARA)
DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage Biopharmaceutical Company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies.
Diabetes is a disease in which the body does not make any insulin or can’t use the insulin it does make as well as it should. Insulin is a hormone made in the body. It helps glucose (sugar) from food enter the cells where it can be used to give the body energy. Without insulin, glucose remains in the blood stream and cannot be used for energy by the cells. Over time, having too much glucose in the blood can cause many health problems.
Diabetes is the leading cause of new blindness, kidney disease, and amputation, and it contributes greatly to the state’s and nation’s number one killer, cardiovascular disease (heart disease and stroke). People with diabetes are more likely to die from flu or pneumonia.
DARA BioSciences, Inc. continues to build a diverse pipeline, including candidates for the treatment of metabolic diseases (diabetes), and pain.
DARA BioSciences, Inc.’s shares are publicly traded on the NASDAQ under the ticker symbol DARA.
DARA BioSciences, Inc. reported that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 collaboration aimed at integrating SurgiVision’s ClearPoint(R) product line with Brainlab’s iMRI product line, with particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance. DARA presently owns over 500,000 shares and warrants of SurgiVision.
For more information about DARA please visit http://www.darabiosciences.com
Orofino Gold Corp. (ORFG)
Orofino Gold Corp. is a Colombia based gold producer founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise.
Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.
The gold mining industry uses a variety of techniques to extract and produce gold. The size and complexity of the mining operation will determine which method is used to extract the gold. The first technique is called panning, which is a manual technique. Gold hunters submerge pans that are filled with gravel or sand into water and shake it, which separates the gold from the other material because it settles to the bottom. Another technique is to use a metal detector, which detects deposits of gold below the surface.
The uses of gold are many and varied. So to buy gold for investment purposes is not the only use to which it is put. Gold has a number of unique properties which make it ideal in industry and perhaps contributes to its value thereby.
Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of Senderos de Oro and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.
Orofino Gold Corp.’s shares are publicly traded on the OTC under the ticker symbol ORFG.
Orofino Gold Corp. recently announced results from random chip samples from within their La Azul mining area in Colombia that indicate very high grades. A complete listing of Acme Analytical Laboratories reports is available on the Company’s website at www.orofinogoldcorp.com.
Highlights
Random chip samples returned high grades to 40.20 grams of gold per tonne in average (or 1.29 troy ounces per tonne) by adopting fusion method (G6Gr).
Random chip samples returned grades to 107.40 grams of silver per tonne in average (adopting aqua regia digestion method - 7AR).
Details
The best results generated 63.30 grams of gold per ton (or two troy ounces of gold per ton) and 202 grams of silver per ton (or six and a half troy ounces of silver per ton).
Chip samples returned 40.20 grams of gold per ton in average (or 1.29 troy ounces per ton).
Chip samples returned 107.20 grams of silver per ton in average (or 3.45 troy ounces per ton).
For more information about Orofino Gold Corp. visit its website www.orofinogoldcorp.com
Buckeye Partners LP (NYSE:BPL) announced that it has priced a public offering of 4,800,000 limited partnership units representing limited partner interests (”LP Units”) at $59.41 per unit. The underwriters have been granted an option to purchase up to 720,000 additional LP Units. Buckeye intends to use the net proceeds from this offering to reduce the indebtedness outstanding under its revolving credit facility.
Barclays Capital, Citi, J.P. Morgan, Morgan Stanley, and Wells Fargo Securities are acting as joint book-running managers of the LP Unit offering. Deutsche Bank Securities and Credit Suisse are acting as the co-managers of the LP Unit offering.
Buckeye Partners, L.P. primarily operates refined petroleum products pipeline systems in the United States. The company’s Pipeline Operations segment transports refined petroleum products, including gasoline, jet fuel, diesel fuel, heating oil, and kerosene to terminals and airports located within end-use markets.
Walgreen Co. (NYSE:WAG) Vice President of Clinical Affairs Dr. David Lorber discussed key trends in specialty pharmacy at the Pinsonault Associates Managed Markets Summit in Miami. The session, titled “Employer Issues in Specialty Pharmacy,” examined the impact for payers, including the role of adherence in cost management and containment, benefit and coverage decisions, formulary and medical policy, pipeline management, provider network and member satisfaction and disruption. Specialty medications include complex treatment regimens and medications that require special delivery, storage and handling. Depending on the condition and prescribed therapy, these medications may be taken orally, intravenously or self-injected.
Walgreen Co., together with its subsidiaries, engages in the operation of a chain of drugstores in the United States. The company’s drugstores sell prescription and non-prescription drugs, and general merchandise.
The Interpublic Group of Companies, Inc. (NYSE:IPG) announced two key strategic moves at its Mediabrands and McCann Erickson units. Effective immediately, Mediabrands will realign its operating units formerly under Mediabrands Ventures to further support its client-centric strategy. In a related development, Matt Freeman will be moving to McCann Erickson in the newly-created post of Vice-Chairman, Global Chief Innovation Officer, reporting to Nick Brien, Chairman and CEO McCann Worldgroup.
The Interpublic Group of Companies, Inc., through its subsidiaries, provides advertising and marketing services worldwide. It delivers various services across marketing disciplines and specialties, including advertising, direct marketing, media buying and planning, public relations, events marketing, Internet and search engine marketing, social media marketing, and mobile marketing.
No comments:
Post a Comment